2016
ECG-Triggered, Single Cardiac Cycle, High-Speed, 3D, Intracoronary OCT
Jang S, Park H, Song J, Kim T, Cho H, Kim S, Bouma B, Kim J, Oh W. ECG-Triggered, Single Cardiac Cycle, High-Speed, 3D, Intracoronary OCT. JACC Cardiovascular Imaging 2016, 9: 623-625. PMID: 27151525, PMCID: PMC5523103, DOI: 10.1016/j.jcmg.2015.11.021.Peer-Reviewed Original ResearchAnimalsArtifactsCardiac-Gated Imaging TechniquesCoronary VesselsDrug-Eluting StentsElectrocardiographyHeart RateImage Interpretation, Computer-AssistedImaging, Three-DimensionalMaleModels, AnimalPercutaneous Coronary InterventionPredictive Value of TestsReproducibility of ResultsSus scrofaTime FactorsTomography, Optical CoherenceIntracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural–molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery
Kim S, Lee M, Kim T, Song J, Nam H, Cho H, Jang S, Ryu J, Oh D, Gweon D, Park S, Park K, Oh W, Yoo H, Kim J. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural–molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery. European Heart Journal 2016, 37: 2833-2844. PMID: 26787442, DOI: 10.1093/eurheartj/ehv726.Peer-Reviewed Original ResearchConceptsHigh-risk plaquesCoronary arteryOptical coherence tomographyIndocyanine greenClinical doseCoherence tomographySwine coronary arteriesLipid-rich plaquesNIRF signalStent-associated complicationsSaline-injected controlsStrong NIRF signalPlaque inflammationPlaque disruptionDES deploymentCoronary imagingFibrous plaquesHuman plaquesInflammationICG uptakeYucatan minipigsPlaquesArteryHistological validationStent struts
2013
Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial
Jang S, Park D, Kim W, Kim Y, Yun S, Kang S, Lee S, Lee C, Park S, Park S. Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial. Catheterization And Cardiovascular Interventions 2013, 81: 1106-1114. PMID: 22899589, DOI: 10.1002/ccd.24603.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiovascular AgentsChi-Square DistributionCoronary AngiographyCoronary Artery DiseaseCoronary ThrombosisDiabetes MellitusDrug-Eluting StentsFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMyocardial InfarctionPaclitaxelPercutaneous Coronary InterventionProportional Hazards ModelsProspective StudiesProsthesis DesignRepublic of KoreaRisk AssessmentRisk FactorsSirolimusTime FactorsTreatment OutcomeConceptsMajor adverse cardiac eventsPaclitaxel-eluting stentsZotarolimus-eluting stentsSirolimus-eluting stentsNondiabetic patientsDiabetic statusDiabetic patientsStent typeIschemia-driven target vessel revascularizationDifferential long-term outcomesLower ratesAdverse cardiac eventsComposite of deathTarget vessel revascularizationLong-term outcomesDifferential treatment effectsSimilar ratesAngiographic characteristicsIschemic complicationsCardiac eventsDiabetes mellitusPrimary outcomeMACE occurrenceStent groupMyocardial infarction